The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of live1
The European Society for Medical Oncology (ESMO) has published a new clinical practice guideline for the diagnosis, treatment, and follow-up of hepat1
The Journal of Hepatology has published a study led by Josep M Llovet’s team at IDIBAPS-Hospital Clínic identifying the molecular characteristics ass1
Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to impr1
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magnet1
A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the first1
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1
A study by the Clínic-IDIBAPS shows that silencing this gene reduces the growth of liver cancer in mice. The research, using different animal mo1
